JP2013535428A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535428A5
JP2013535428A5 JP2013518819A JP2013518819A JP2013535428A5 JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5 JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5
Authority
JP
Japan
Prior art keywords
rsv
polypeptide
composition
polypeptide epitope
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013518819A
Other languages
English (en)
Japanese (ja)
Other versions
JP5890407B2 (ja
JP2013535428A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/043136 external-priority patent/WO2012006395A1/en
Publication of JP2013535428A publication Critical patent/JP2013535428A/ja
Publication of JP2013535428A5 publication Critical patent/JP2013535428A5/ja
Application granted granted Critical
Publication of JP5890407B2 publication Critical patent/JP5890407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013518819A 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法 Active JP5890407B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36202910P 2010-07-07 2010-07-07
US61/362,029 2010-07-07
US201161485669P 2011-05-13 2011-05-13
US61/485,669 2011-05-13
PCT/US2011/043136 WO2012006395A1 (en) 2010-07-07 2011-07-07 Respiratory syncytial virus antigenic compositions and methods

Publications (3)

Publication Number Publication Date
JP2013535428A JP2013535428A (ja) 2013-09-12
JP2013535428A5 true JP2013535428A5 (OSRAM) 2014-08-07
JP5890407B2 JP5890407B2 (ja) 2016-03-22

Family

ID=45438747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518819A Active JP5890407B2 (ja) 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法

Country Status (13)

Country Link
US (1) US9487593B2 (OSRAM)
EP (1) EP2590675B1 (OSRAM)
JP (1) JP5890407B2 (OSRAM)
CN (2) CN103037898B (OSRAM)
AU (1) AU2011276251B2 (OSRAM)
BR (1) BR112013000345B1 (OSRAM)
CA (1) CA2799934C (OSRAM)
DK (1) DK2590675T3 (OSRAM)
ES (1) ES2688993T3 (OSRAM)
IL (1) IL222723B (OSRAM)
MX (1) MX340796B (OSRAM)
RU (1) RU2609661C2 (OSRAM)
WO (1) WO2012006395A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
EA201891945A3 (ru) * 2012-08-01 2019-05-31 Бавариан Нордик А/С Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
CN105555301B (zh) 2013-08-13 2021-04-16 西北大学 肽缀合颗粒
CN106457302B (zh) 2014-05-27 2020-04-17 人工细胞科技公司 通过tff进行多层涂覆芯的自动化逐层构造
US9630994B2 (en) 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
US9968665B2 (en) 2015-09-16 2018-05-15 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US20170230649A1 (en) * 2016-02-05 2017-08-10 Qualcomm Incorporated Calibration of hybrid auto focus (af) imaging systems
SG11201908999QA (en) 2017-04-04 2019-10-30 Univ Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
US11773143B2 (en) 2017-10-13 2023-10-03 Trellis Bioscience, Llc Conformational epitopes in respiratory syncytial virus G protein central conserved region
CA3095216A1 (en) 2018-02-28 2019-09-06 University Of Washington Self-asssembling nanostructure vaccines
EP3833677A4 (en) 2018-08-08 2022-04-27 Trellis Bioscience, Inc. IMPROVED RSV PASSIVE AND ACTIVE VACCINES
US20230414526A1 (en) * 2022-03-29 2023-12-28 Artificial Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677090B2 (en) * 1993-08-06 1997-04-10 Connaught Laboratories Limited Inactivated respiratory syncytial viral vaccines
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
ATE178906T1 (de) 1994-08-25 1999-04-15 Stichting Inst Dierhouderij Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen
FR2726471B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
AUPO026596A0 (en) * 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
ES2316487T5 (es) 2000-10-18 2019-05-13 The Government Of The Us Secretary Department Of Health And Human Services Composiciones y métodos para modular la inmunidad e infección de RSV
FR2819810B1 (fr) 2001-01-23 2004-05-28 Pf Medicament Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
AUPR520201A0 (en) 2001-05-23 2001-06-14 Commonwealth Scientific And Industrial Research Organisation Antiviral compounds
JP3997930B2 (ja) 2003-02-27 2007-10-24 富士ゼロックス株式会社 カーボンナノチューブの製造装置および製造方法
US7368537B2 (en) 2003-07-15 2008-05-06 Id Biomedical Corporation Of Quebec Subunit vaccine against respiratory syncytial virus infection
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) * 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
EP1768993A4 (en) 2004-06-16 2008-07-23 Univ Johns Hopkins CYSTIC REGION OF HUMAN RESPIRATORY SYNZYTIAL VIRUS AND METHOD OF USE THEREOF
US20080131450A1 (en) 2004-07-23 2008-06-05 Pierre Fabre Medicament Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions
US20080171070A1 (en) * 2005-01-31 2008-07-17 Pierre Schaaf Polyelectrolyte Multilayer Film, Preparation And Uses Thereof
US20090220537A1 (en) * 2005-04-12 2009-09-03 The University Of Queensland Vaccine delivery system
EP2308900B1 (en) 2005-10-25 2014-02-12 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
EP1972348A1 (en) 2007-03-14 2008-09-24 Pierre Fabre Medicament Novel vaccine composition for the treatment of respiratory infectious diseases
CA2684578A1 (en) 2007-03-21 2008-09-25 Id Biomedical Corporation Of Quebec Chimeric antigens
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
WO2009079066A2 (en) * 2007-09-26 2009-06-25 Aparna Biosciences Therapeutic and vaccine polyelectrolyte nanoparticle compositions
EP2058002A1 (en) * 2007-10-31 2009-05-13 Bestewil Holding B.V. Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine
US20110177117A1 (en) 2008-07-18 2011-07-21 Normand Blais Chimeric respiratory syncytial virus polypeptide antigens
WO2010075491A2 (en) 2008-12-24 2010-07-01 University Of Rochester Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
CA2770304C (en) 2009-08-04 2019-11-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Anti-rsv immunogens and methods of immunization
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Similar Documents

Publication Publication Date Title
RU2013101972A (ru) Антигенные композиции респираторного синцитиального вируса и способы
JP2015530973A5 (OSRAM)
JP2017529067A5 (OSRAM)
JP2013172734A5 (OSRAM)
JP2017160222A5 (OSRAM)
JP2018532382A5 (OSRAM)
JP2018510132A5 (OSRAM)
HRP20190799T1 (hr) Imunocitokini na bazi il-15 i sushi domene il-15r alfa
FI3430027T3 (fi) Peptidi käytettäväksi ei-pienisoluisen keuhkosyövän ja pienisoluisen keuhkosyövän hoidossa
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
JP2016185981A5 (OSRAM)
JP2018523483A5 (OSRAM)
JP2018029594A5 (OSRAM)
CN103417480A (zh) 一种靶向整合素受体的新型多肽修饰的肿瘤靶向脂质体
JP2016196472A5 (OSRAM)
JP2017527272A5 (OSRAM)
JP2015509085A5 (OSRAM)
JP2019516663A5 (OSRAM)
JP2014110810A5 (OSRAM)
JP2019531093A5 (OSRAM)
HK1200842A1 (en) Proteins with improved half-life and other properties
JP2013518057A5 (OSRAM)
JP2013541335A5 (OSRAM)
JP2020500510A5 (OSRAM)
JP2019536426A5 (OSRAM)